Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
IJMS | Free Full-Text | Detailed Structure and Pathophysiological Roles of the IgA-Albumin Complex in Multiple Myeloma
Diagnosis and Initial Treatment of Multiple Myeloma Natalie S. Callander, M.D Professor of Medicine
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Dutcher bodies in IgA multiple myeloma | SpringerLink
PDF] Multiple myeloma associated with IgA lambda gammopathy and multiple myeloma oncogene 1 in a Yorkshire terrier | Semantic Scholar
Auer rod-like inclusions in multiple myeloma: Report of two diagnostically challenging cases
What is the Difference Between Kappa and Lambda Light Chains | Compare the Difference Between Similar Terms
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Pseudo-monoclonal gammopathy: a report of four cases. - Abstract - Europe PMC